vs
Lakeshore Acquisition III Corp.（LCCC）与Lucid Diagnostics Inc.（LUCD）财务数据对比。点击上方公司名可切换其他公司
Lucid Diagnostics Inc.的季度营收约是Lakeshore Acquisition III Corp.的1.7倍（$1.2M vs $717.3K），Lakeshore Acquisition III Corp.净利率更高（67.9% vs -858.5%，领先926.4%）
Lucid Diagnostics Inc.是一家处于商业化阶段的医疗诊断企业，专注于研发和推广上消化道疾病相关非侵入性筛查产品，核心覆盖食管癌及癌前病变早筛领域，主要为美国境内医疗机构及临床合作伙伴提供相关解决方案。
LCCC vs LUCD — 直观对比
营收规模更大
LUCD
是对方的1.7倍
$717.3K
净利率更高
LCCC
高出926.4%
-858.5%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $717.3K | $1.2M |
| 净利润 | $486.8K | $-10.4M |
| 毛利率 | — | — |
| 营业利润率 | -32.1% | -971.0% |
| 净利率 | 67.9% | -858.5% |
| 营收同比 | — | 3.3% |
| 净利润同比 | — | 16.0% |
| 每股收益（稀释后） | $0.08 | $-0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LCCCLUCD
| Q3 25 | $717.3K | $1.2M | ||
| Q2 25 | $467.3K | $1.2M | ||
| Q1 25 | — | $828.0K | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $976.0K | ||
| Q1 24 | — | $1.0M | ||
| Q4 23 | — | $1.0M |
净利润LCCCLUCD
| Q3 25 | $486.8K | $-10.4M | ||
| Q2 25 | $216.5K | $-4.4M | ||
| Q1 25 | — | $-26.9M | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | — | $-12.4M | ||
| Q2 24 | — | $-11.0M | ||
| Q1 24 | — | $-10.6M | ||
| Q4 23 | — | $-10.8M |
营业利润率LCCCLUCD
| Q3 25 | -32.1% | -971.0% | ||
| Q2 25 | -53.7% | -978.8% | ||
| Q1 25 | — | -1508.1% | ||
| Q4 24 | — | -1033.8% | ||
| Q3 24 | — | -997.8% | ||
| Q2 24 | — | -1146.7% | ||
| Q1 24 | — | -1078.1% | ||
| Q4 23 | — | -1101.3% |
净利率LCCCLUCD
| Q3 25 | 67.9% | -858.5% | ||
| Q2 25 | 46.3% | -381.7% | ||
| Q1 25 | — | -3249.8% | ||
| Q4 24 | — | -964.2% | ||
| Q3 24 | — | -1055.5% | ||
| Q2 24 | — | -1127.6% | ||
| Q1 24 | — | -1060.1% | ||
| Q4 23 | — | -1041.3% |
每股收益（稀释后）LCCCLUCD
| Q3 25 | $0.08 | $-0.10 | ||
| Q2 25 | $0.06 | $-0.08 | ||
| Q1 25 | — | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.40 | ||
| Q4 23 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $47.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-1.6M | $25.8M |
| 总资产 | $71.0M | $53.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LCCCLUCD
| Q3 25 | — | $47.3M | ||
| Q2 25 | — | $31.1M | ||
| Q1 25 | — | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $24.9M | ||
| Q1 24 | — | $24.8M | ||
| Q4 23 | — | $18.9M |
股东权益LCCCLUCD
| Q3 25 | $-1.6M | $25.8M | ||
| Q2 25 | $-1.4M | $7.9M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $11.9M | ||
| Q4 23 | — | $-2.3M |
总资产LCCCLUCD
| Q3 25 | $71.0M | $53.2M | ||
| Q2 25 | $70.5M | $38.7M | ||
| Q1 25 | — | $32.8M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $34.1M | ||
| Q1 24 | — | $32.0M | ||
| Q4 23 | — | $27.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-206.3K | $-10.9M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.42× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LCCCLUCD
| Q3 25 | $-206.3K | $-10.9M | ||
| Q2 25 | $-218.3K | $-10.5M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $-9.9M | ||
| Q3 24 | — | $-10.2M | ||
| Q2 24 | — | $-11.5M | ||
| Q1 24 | — | $-12.6M | ||
| Q4 23 | — | $-10.0M |
现金转化率LCCCLUCD
| Q3 25 | -0.42× | — | ||
| Q2 25 | -1.01× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
